Recent Finacing
Recent Raise
Synosia Therapeutics (Basel) develops clinical-stage biotherapeutics for neurological and psychiatric disorders, advancing six clinical compounds—including SYN-115 and SYN-118 for Parkinson’s—under a collaboration with UCB.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors